Siemens Healthineers invested $300M in the Walpole, Mass. laboratory diagnostics manufacturing facility bringing up to 700 local, high-tech jobs to Massachusetts. The facility manufactures assays for ...

Germany-based Siemens and New York-based Pfizer have entered a master collaboration deal to design, develop and market in vitro diagnostic tests for Pfizer’s therapeutic products, according to a news ...

While aiming to double its manufacturing capacity to more than 50 million blood tests per month, Siemens Healthineers has begun shipping its COVID-19 serology kits internationally, for use on about 20 ...

Siemens Healthineers announced today it is significantly expanding its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic ...

Siemens Healthineers has announced the availability of two blood-based biomarker tests for research use: the Atellica IM ...

Siemens Healthineers has cut the red ribbon on a new €10m ($11.85m) centre of excellence focused on immunoassay instrument R&D in Swords, Ireland. The centre, situated in a facility nearby Siemens ...

To help create a unique hands-on experience for customers, interactive touch screens are “connected” to an automation track and showcase valuable information about Siemens' performance-driven systems ...

Siemens Healthineers received European approval for a blood test designed to help predict the risk of recurrence among patients with relapsing multiple sclerosis. The company’s CE-marked in vitro ...